Benitec Biopharma Inc. (BNTC)
NASDAQ·Healthcare·Biotechnology
$9.47
-0.79%
Mkt Cap $298.17M
Analyst Ratings
No recent rating data.
Price Target (12 analysts)
$18.67
Range $14.00 – $25.00
Implied Upside
+97.3%
Consensus $18.67 vs current $9.47
NASDAQ·Healthcare·Biotechnology
$9.47
-0.79%
Mkt Cap $298.17M
No recent rating data.
Price Target (12 analysts)
$18.67
Range $14.00 – $25.00
+97.3%
Consensus $18.67 vs current $9.47